Colitis-Aid.com

The chamomile plant, also known as wild chamomile, is one of the oldest used medicinal plants. It grows everywhere, at the sides of the roads, on fields, near the houses. In some regions, fields of chamomile lie. The flowers - Flores Chamomile- contain volatile oil, blue-colored, with antispasmodic, disinfectant and antiinflammatory characteristics.

(more…)

How Inflammation Can Cause Disease And Pain

More: continued here

I’m sure you’ve heard everyone saying it - the best way to live your life is through a high-fiber diet. Health expert after health expert is telling us this. Even the American Dietetic Association, the Surgeon General, and the National Cancer Institute are pushing the importance of making sure you…

More: continued here

Mayo Clinic researchers have found that certolizumab pegol is an effective treatment for adults with Crohn’s disease, according to two new studies. These findings were published in  the New England Journal of Medicine. Certolizumab pegol blocks tumor necrosis factor, an important cause of inflammation in Crohn’s disease.

Crohn’s disease is an inflammatory disorder of the gastrointestinal tract that affects an estimated 500,000 people in the United States. Symptoms include abdominal pain, fever, nausea, vomiting, weight loss and diarrhea. Crohn’s disease has no known medical cure. Currently approved therapies that also block tumor necrosis factor include intravenous infusions of infliximab or subcutaneous injections of adalimumab.

(more…)

A newly discovered gene may help protect carriers against Crohn’s disease and colitis, inflammatory bowel diseases (IBDs) that affect an estimated one million Americans, researchers say.The gene produces a protein that’s key to a cellular receptor for interleukin-23 (IL-23), a protein involved in the body’s inflammatory processes, explains a report published in the Oct. 27 issue of Science.“We’re pleased about the finding because the IL-23 pathway is already known to be important in inflammatory conditions such as asthma,” said lead researcher Dr. Richard H. Duerr, associate professor of medicine and human genetics at the University of Pittsburgh. “We were surprised because the most common variant of the gene provides protection. If we could understand what the protective variant is doing and how it affects downstream events, we could find ways to treat or prevent IBD.”